Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide - PubMed (original) (raw)
Clinical Trial
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide
Javier Daniel Finkielman et al. Am J Hypertens. 2005 Mar.
Abstract
Background: Differences between the antihypertensive responses to drug therapy measured by office blood pressure (OBP) and ambulatory blood pressure monitoring (ABPM) techniques have been noted but rarely analyzed. We studied whether the OBP and 24-h ABPM responses to hydrochlorothiazide differ and, if so, the relevance of these differences.
Methods: The OBP and ABPM responses to hydrochlorothiazide (25 mg/d, for 4 weeks) were measured in 228 subjects with essential hypertension, and mean responses were compared between methods using the Student paired t test. To assess variation in the agreement between OBP and ABPM responses among subjects, the limits of agreement were calculated as the mean difference between OBP and ABPM responses +/-2 standard deviations.
Results: The mean systolic OBP response was 4.8 mm Hg greater than the response measured by ABPM (-14.3 v -9.5 mm Hg, P < .001), and the mean diastolic OBP response was 2.1 mm Hg greater than the response measured by ABPM (-7.5 v -5.5, P < .001). The limits of agreement between the OBP and ABPM responses ranged from -18.7 to +28.2 mm Hg for systolic response and from -12.9 to +17.1 mm Hg for diastolic response. The systolic and diastolic OBP and ABPM responses were in opposite directions in 22.8% and 23.7% of the subjects, respectively.
Conclusions: Compared to ABPM, OBP overestimates the mean systolic and mean diastolic blood pressure responses to hydrochlorothiazide. Variation among subjects in the magnitude and direction of responses renders OBP an unreliable predictor of ABPM responses.
Similar articles
- Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring.
Martina B, Weinbacher M, Gasser P, Rhyner K, Köhler M, Wohler D, LeBloch Y, Bart T. Martina B, et al. J Cardiovasc Pharmacol. 1994;24 Suppl 3:S89-92. J Cardiovasc Pharmacol. 1994. PMID: 7700075 Clinical Trial. - Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M. Guerrero P, et al. Clin Exp Hypertens. 2008 Oct;30(7):553-64. doi: 10.1080/10641960802441906. Clin Exp Hypertens. 2008. PMID: 18855259 Clinical Trial. - Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.
Sánchez RA, Boggia J, Peñaherrera E, Barroso WS, Barbosa E, Villar R, Cobos L, Hernández Hernández R, Lopez J, Octavio JA, Parra Carrillo JZ, Ramírez AJ, Parati G. Sánchez RA, et al. J Clin Hypertens (Greenwich). 2020 Apr;22(4):527-543. doi: 10.1111/jch.13816. Epub 2020 Feb 12. J Clin Hypertens (Greenwich). 2020. PMID: 32049441 Free PMC article. Review. - [Ambulatory blood pressure monitoring (ABPM) and management of hypertension].
Shimada K. Shimada K. Nihon Naika Gakkai Zasshi. 2002 Sep 20;91 Suppl:303-8. Nihon Naika Gakkai Zasshi. 2002. PMID: 12580133 Review. Japanese. No abstract available.
Cited by
- The pharmacogenetics research network: from SNP discovery to clinical drug response.
Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network. Giacomini KM, et al. Clin Pharmacol Ther. 2007 Mar;81(3):328-45. doi: 10.1038/sj.clpt.6100087. Clin Pharmacol Ther. 2007. PMID: 17339863 Free PMC article. Review. - All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
Ernst ME, Carter BL, Basile JN. Ernst ME, et al. J Clin Hypertens (Greenwich). 2009 Jan;11(1):5-10. doi: 10.1111/j.1751-7176.2008.00009.x. J Clin Hypertens (Greenwich). 2009. PMID: 19125852 Free PMC article. No abstract available. - Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Johnson JA, Boerwinkle E, Zineh I, Chapman AB, Bailey K, Cooper-DeHoff RM, Gums J, Curry RW, Gong Y, Beitelshees AL, Schwartz G, Turner ST. Johnson JA, et al. Am Heart J. 2009 Mar;157(3):442-9. doi: 10.1016/j.ahj.2008.11.018. Am Heart J. 2009. PMID: 19249413 Free PMC article. Clinical Trial. - Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
Turner ST, Schwartz GL, Chapman AB, Beitelshees AL, Gums JG, Cooper-Dehoff RM, Boerwinkle E, Johnson JA, Bailey KR. Turner ST, et al. J Transl Med. 2012 Mar 13;10:47. doi: 10.1186/1479-5876-10-47. J Transl Med. 2012. PMID: 22413836 Free PMC article. Clinical Trial. - Randomized, Double-Blind Clinical Trial to Assess the Acute Diuretic Effect of Equisetum arvense (Field Horsetail) in Healthy Volunteers.
Carneiro DM, Freire RC, Honório TC, Zoghaib I, Cardoso FF, Tresvenzol LM, de Paula JR, Sousa AL, Jardim PC, da Cunha LC. Carneiro DM, et al. Evid Based Complement Alternat Med. 2014;2014:760683. doi: 10.1155/2014/760683. Epub 2014 Mar 4. Evid Based Complement Alternat Med. 2014. PMID: 24723963 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical